NMG

Prkdc and Il2rg genes were both knocked-out in NOD mice. 

• Lacking mature T, B and NK cells
• Low immune rejection against human cells and tissues
• Good tumorigenicity so that a small number of cells can form tumors.
• Significant improvement in the survival of transplanted human cells and tissues
• Suitable for the transplantation of human hematopoietic stem cells and the preparation of humanized mouse models
• Suitable as the carrier mice for the transplantation of heterologous cells and tissues

Figure 1. Complete deletion of T, B and NK cells in the spleen of NMG mice.(A) The splenocytes of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of T, B and NK cells by FACS. (B) Statistical analysis of sorted cells.

Figure 2. Complete deletion of T, B and NK cells in the blood of NMG mice.(A) The peripheral blood samples of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of T, B and NK cells by FACS.(B) Statistical analysis of sorted cells.

Figure 3. Compositions of monocytes, macrophages, DCs in the spleen of NMG mice. (A) The splenocytes of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of monocytes, macrophages, DCs. (B) Statistical analysis of sorted cells.

Figure 4. Compositions of monocytes, macrophages, DCs in the blood of NMG mice. (A) The peripheral blood samples of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of monocytes, macrophages, DCs. (B) Statistical analysis of sorted cells.

Figure 5. Histological sections of various tissues from NMG mice. Furthermore, no significant abnormalities were observed in other tissues, including brain, retina, spinal cord, heart, liver, lung, kidney, small intestine, large intestine, stomach, salivary glands, pancreas, ovary, uterus, testis, epididymis, skeletal muscle, skin, and brown fat. 

Fig6.Serum antibody response in the serum of BALB/c, NOD-SCID, NMG and Blank. (n=5, 8-week-old, male)

Fig7. The establishment of tumor models using A549 or Raji cells is more effective in NMG mice.

A CDX model has been successfully established in NMG mice

Fig8. In vivo Efficacy Study of Anti-human CD47 Reference Antibody in the Treatment of Raji lymphoma CDX Tumor model in NMG mice.

Fig9. CAR-T in vivo efficacy study of A549 NSCLC model in NMG mice

Fig10. PBMC reconstitution model. Human PBMC cells were intravenous implanted into homozygote NMG mice. Percentage of human CD45+ cells (A),  body weight (B).

Fig11.  In vivo Efficacy Study of Hu-PBMC Reconstruction Model in NMG mice.

Fig12. Analysis of peripheral blood lymphocyte subpopulations of NMG mice after implantation of human CD34+ HSC at different times.

Fig13. Drug efficacy evaluation study performed in NMG mice reconstituted with hCD34+ cells. Humanized NMG mice reconstituted with human CD34+ cells were i.v. injected with MDA-MB-231 cells.

Peptide Self-Assembly Nanoparticles Loaded with Panobinostat to Activate Latent Human Immunodeficiency Virus
References：J Biomed Nanotechnol

SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
References：NAT COMMUN

A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
References：SCI TRANSL MED

Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
References：Front. Immunol

Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
References：Cancers

4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
References：Frontiers in Immunology

A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T cell for Precise Cancer Cell Targeting
References：A Journal of the Gesellschaft Deutscher Chemiker

Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
References：Molecular Cancer

An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
References：Molecular Therapy

Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
References：SCIENCE ADVANCES

T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
References：nature communications

Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
References：International Journal of Molecular Sciences

Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
References：NATURE MATERIALS

An oncolytic virus–T cell chimera for cancer immunotherapy
References：NATURE BIOTECHNOLOGY

The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
References：Cancer Discovery

Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
References：Cell Metabolism

Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
References：Cell Metabolism

A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
References：Molecular Cancer

Photo-metallo-immunotherapy: Fabricating Chromium-Based Nanocomposites to Enhance CAR-T Cell Infiltration and Cytotoxicity against Solid Tumors
References：ADVANCED MATERIALS

FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
References：Nature Communications

Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
References：Nature Communications

PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
References：Nature Communications

Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
References：Nature Communications

Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT-PD-L1 Axis
References：Advanced Science

Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development
References：Advanced Science

A pan-KRAS degrader for the treatment of KRAS-mutant cancers
References：Cell Discovery

Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
References：CANCER RESEARCH

HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy
References：Theranostics

Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
References：Gut Microbes

Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
References：MOLECULAR THERAPY

Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
References：Cell Reports Medicine

iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation
References：MedComm

Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
References：JOURNAL OF NANOBIOTECHNOLOGY

RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
References：Journal for ImmunoTherapy of Cancer

Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification
References：PHARMACOLOGICAL RESEARCH

miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair
References：JACC-Basic to Translational Science

Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis
References：International Journal of Biological Sciences

LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
References：Cell Death & Disease

Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
References：Cell Death & Disease

Small extracellular vesicle piR-hsa-30937 derived from pancreatic neuroendocrine neoplasms upregulates CD276 in macrophages to promote immune evasion
References：Cancer Immunology Research

Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
References：Cell Reports

Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation
References：Stem Cell Research & Therapy

Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation
References：PHYTOMEDICINE

Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer
References：OncoImmunology

PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
References：Frontiers in Immunology

INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib
References：BIOCHEMICAL PHARMACOLOGY

The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML
References：MOLECULAR CANCER THERAPEUTICS

TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
References：LIFE SCIENCES

FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
References：Communications Biology

IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
References：INTERNATIONAL IMMUNOPHARMACOLOGY

ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer
References：Translational Oncology

HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
References：INTERNATIONAL JOURNAL OF ONCOLOGY

Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
References：EJNMMI Radiopharmacy and Chemistry

Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS
References：EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles
References：SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity
References：ACS Omega

FYB1-targeted modulation of CAPG promotes AML progression
References：MOLECULAR AND CELLULAR BIOCHEMISTRY

PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
References：DNA AND CELL BIOLOGY

Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice
References：Journal of Gastrointestinal Oncology